Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Combinations for PONV Prevention in Cesarean Section
NCT06810531Phase 4Completed
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metoclopramide and dexamethasone in postoperative nausea and vomiting (PONV) and intraoperative nausea and vomiting (IONV) (2 arms). Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Feb 2025; status: completed.
02
Drugs
metoclopramidedexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)intraoperative nausea and vomiting (IONV)
Beyond the preview
Go deeper on NCT06810531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810531.